Composition Range Cancer Therapeutics ETF - USD

ETF

CNCR

US26922A8264

Temps Différé Nasdaq 17:34:40 06/05/2024 Varia. 5j. Varia. 1 janv.
15,69 USD -1,07% Graphique intraday de Range Cancer Therapeutics ETF - USD +4,39% +16,48%

Composition du Range Cancer Therapeutics ETF - USD

Poids
7,985 USD -12,73%-9,73%+61,65%2,84%
39,23 USD -2,41%+6,04%+37,20%2,32%
4,125 USD -1,55%+8,03%-36,26%2,27%
15,76 USD +0,54%+6,55%+64,14%2,09%
106,9 USD -0,27%+14,61%+15,67%1,77%
4,165 USD +2,59%+3,47%+11,76%1,76%
51,86 USD -1,57%+0,53%-7,42%1,69%
31,76 USD -3,24%-0,56%-22,93%1,69%
34,28 USD +0,38%+0,26%-9,87%1,64%
3,515 USD +1,59%+10,60%+50,65%1,62%
13,82 USD +1,43%+15,00%+70,17%1,60%
69,41 USD -1,34%+1,88%-5,93%1,56%
9,2 USD 0,00%+10,56%-11,36%1,55%
4,445 USD +1,25%+14,95%+70,88%1,49%
17,29 USD +0,82%+11,16%+152,64%1,45%
20,94 USD +1,53%+4,29%+45,48%1,42%
45,7 USD +1,31%-1,92%+24,82%1,39%
38,16 USD +2,05%+9,67%+49,29%1,38%
4,96 USD +6,21%+6,49%-23,24%1,31%
60,88 USD +1,07%+4,99%-10,71%1,28%
8,29 USD -0,48%+4,95%-66,72%1,28%
3,94 USD +2,07%+2,60%-7,73%1,28%
2,435 USD +3,18%+8,00%+25,26%1,23%
22,57 USD +2,36%+5,92%+4,30%1,22%
9,115 USD +3,11%+11,22%-7,51%1,22%
42,68 USD +1,17%+4,11%+18,94%1,21%
25,38 USD -0,02%+0,40%+57,35%1,20%
7,81 USD +2,63%-1,14%-21,41%1,19%
6,99 USD -0,71%+5,01%-37,15%1,19%
13,3 USD +4,03%+7,06%+29,36%1,19%
9,895 USD -1,74%+2,27%+19,37%1,17%
3,205 USD -0,47%+8,47%+111,92%1,16%
61,95 USD -4,37%+8,63%+467,75%1,16%
47,44 USD -1,89%+5,50%+73,05%1,13%
24,02 USD +1,41%-1,81%-32,97%1,11%
4,93 USD +3,57%+6,29%+14,25%1,11%
1,725 USD -4,17%-0,57%-23,11%1,10%
3,9 USD +1,83%+10,37%-9,44%1,09%
21,92 USD +0,11%-7,88%-8,88%1,09%
16,86 USD -1,81%+3,03%+16,30%1,06%
953,9 USD -0,33%+6,72%+8,44%1,05%
6,07 USD +1,34%+2,79%-8,68%1,02%
24,33 USD +0,91%+15,28%+14,41%1,02%
27,99 USD -1,27%+2,06%+171,64%1,01%
112c6046aef8901a.r332wgeE0M_nIi6bctWzcu49tGnLYVRmEVEUtSZctSk.4g2Y90zDsYeNVWb_R4rDOa1bxieILT0yayN45G8K0Gr8MJykNuKjvohkQQ

Description

Code ISIN US26922A8264
Frais de gestion (TER) 0.79%
Catégories d'actif
Secteur
Taille
Devise
Société de gestion
Sous-jacent Range Oncology Therapeutics Index - USD

Caractéristiques

Juridiction
Structure du fonds
Méthode de réplication
Modèle de réplication
Date de création
18/03/2015
Politique de dividendes
Objectif géographique

Distribution

Investisseur Particulier

Évolutions des encours ( 28/03/2024 )

Encours (EUR) 27 M€
Encours 1 mois 18 M€
Encours 3 mois 13 M€
Encours 6 mois 8 M€
Encours 12 mois 16 M€
  1. Bourse
  2. ETF
  3. ETF CNCR
  4. Composition Range Cancer Therapeutics ETF - USD